Search
  • 网站搜寻
亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台,协助业界发掘知识产权贸易商机,并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权,或是制造商需要购买技术以提高操作效能,又或是知识产权配套服务供应商,你将会从本网站发掘到有用的知识产权贸易资讯。
返回搜索结果

STRONG AGONIST INSULIN MIMETOPE USED IN VACCINATION TO PREVENT TYPE 1 DIABETES DEVELOPMENT


技术优势

Type I Diabetes


技术应用

Vaccination with strongly agonistic insulin mimetopes in combination with drug(s) that potentiate Tregs conversion to prevent development of type 1 diabetes in humans at risk for the disease.


详细技术说明

Autoimmune T-cells with low affinity to insulin epitopes are considered to be a cause of type 1 diabetes development. The attempts to stop autoimmune attack by converting naive T cells to regulatory T cells (Tregs) using natural insulin peptides have failed in clinical trials. The DFCI scientists developed strategy to use specifically modified insulin mimetopes that are stronger agonists than natural ligand to efficiently induce Tregs and prevent diabetes development in NOD mouse model of the disease.


附加资料

Inventor: von Boehmer, Harald | Daniel, Carolin
Priority Number: US20110311536A1
IPC Current: A61K0039395 | A61K003900 | A61K003902 | A61K0039235 | A61P003704 | A61P003708 | C07K000706 | C07K001900
US Class: 4241341 | 4241841 | 4241981 | 4242331 | 4242341 | 4242751 | 530329 | 5303873
Assignee Applicant: Dana-Farber Cancer Institute Inc.,Boston
Title: PREVENTION OF TYPE 1 DIABETES BY TREG VACCINATION WITH AN INSULIN MIMETOPE
Usefulness: PREVENTION OF TYPE 1 DIABETES BY TREG VACCINATION WITH AN INSULIN MIMETOPE
Summary: The method is useful for increasing Treg cells specific for an antigen in a subject who is a candidate for a transplant (where the antigen is present in the transplant but not in the subject) and who does not have detectable cytotoxic T cells specific for the antigen, to treat transplant rejection and autoimmune diseases including multiple sclerosis, autoimmune myocarditis, pemphigus, celiac disease, myasthenia gravis, Hashimoto's thyroiditis, Graves disease, Addison's disease, chronic Lyme arthritis, Goodpasture's syndrome, Kawasaki disease, scleroderma, Sjogren's syndrome (all claimed), immunoglobulin E-mediated allergy, allergic symptoms or type I diabetes. No biological data given.
Novelty: Increasing regulatory T cells specific for an antigen in subject, useful to treat e.g. transplant rejection, Kawasaki disease and autoimmune myocarditis, comprises administering a mimotope of the antigen under sub-immunogenic conditions


主要类别

诊断/治疗


细分类别

其他疾病


国家/地区

美国

欲了解更多信息,请点击 这里
Business of IP Asia Forum
桌面版